Semustine
Term · Oncology and biomedicine · MLC-T-ONC-007658
A substance that has been studied in the treatment of some types of cancer. Semustine damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea.
A methylated derivative of carmustine with antineoplastic activity. As an alkylating agent, semustine forms covalent linkages with nucleophilic centers in DNA, causing depurination, base-pair miscoding, strand scission, and DNA-DNA cross-linking, which may result in cytotoxicity.
| Identifier | MLC-T-ONC-007658 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MeCCNU |
| Synonyms | CCNU, methyl-; MCCNU; methyl CCNU; methyl-CCNU |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-007658",
"term": "Semustine",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that has been studied in the treatment of some types of cancer. Semustine damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea.",
"A methylated derivative of carmustine with antineoplastic activity. As an alkylating agent, semustine forms covalent linkages with nucleophilic centers in DNA, causing depurination, base-pair miscoding, strand scission, and DNA-DNA cross-linking, which may result in cytotoxicity."
],
"abbreviation": "MeCCNU",
"synonyms": [
"CCNU, methyl-",
"MCCNU",
"methyl CCNU",
"methyl-CCNU"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/semustine/"
}
Record 14,824 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.